BTC Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-6,191
Closed -$506K – 245
2023
Q2
$506K Sell
6,191
-235
-4% -$18.9K 0.05% 160
2023
Q1
$475K Buy
6,426
+133
+2% +$10.3K 0.05% 153
2022
Q4
$522K Sell
6,293
-39
-0.6% -$3.1K 0.06% 149
2022
Q3
$450K Buy
6,332
+28
+0.4% +$2.42K 0.06% 156
2022
Q2
$549K Buy
6,304
+144
+2% +$13.5K 0.07% 152
2022
Q1
$663K Buy
6,160
+2,120
+52% +$219K 0.07% 154
2021
Q4
$524K Buy
4,040
+2,196
+119% +$269K 0.05% 173
2021
Q3
$223K Sell
1,844
-264
-13% -$32.1K 0.03% 188
2021
Q2
$237K Sell
2,108
-628
-23% -$66.1K 0.03% 192
2021
Q1
$261K Sell
2,736
-36
-1% -$3.28K 0.03% 203
2020
Q4
$220K Buy
+2,772
New +$201K 0.03% 211

Other funds holding TECH

BTC Capital Management's TECH Position: Q3 2023 in Review

BTC Capital Management sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 6,191 shares — an estimated $506K sold.

BTC Capital Management first reported a position in TECH in Q4 2020 and held it in 11 quarters. The position peaked at $663K in Q1 2022. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • BTC Capital Management reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
  • BTC Capital Management sold 6,191 Bio-Techne shares in Q3 2023, an estimated $506K.
  • BTC Capital Management first reported a position in Bio-Techne in Q4 2020 and held it in 11 quarters.
  • BTC Capital Management's Bio-Techne position peaked at $663K in Q1 2022.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on BTC Capital Management's 13F filing for Q3 2023, filed 17 Oct 2023.